Teske, Kelly
kelly.teske@wmich.eduWestern Michigan University

Teske, Kelly

Department of Chemistry

Year of Graduation: 2015
Research Lab: Prof. Alexander Arnold
Major Area of Focus:
Minor Area of Focus:

Thesis: Part I. The Development of Non-secosteroidal Vitamin D Receptor Modulators Part II. The Development of a Universal GTP-ase Assay 

Previously Attended

Illinois State University, 2006-2010, B.S., Chemistry and Biochemistry & Molecular Biology

University of Wisconsin-Milwaukee, 2010-2015, Ph.D, Chemistry

Why I like Chemistry

I like chemistry because of the challenges it presents. There is always something new to learn and discover.

Why I chose the Chemistry and Biochemistry Program at UW-Milwaukee

I chose to do chemistry at UW-Milwaukee because I was impressed with the medicinal chemistry and drug discovery research done by many of the synthetic organic groups.

Favorite things to do in Milwaukee

Going to Bradford Beach and playing volleyball

Research Goals

Thesis Title: "Part 1. The Development of Non-Secosteroidal Vitamin D Receptor Modulators and Part 2. The Development of a Universal GTPase Assay"

Research Description:  Part 1. VDR is a therapeutically relevant drug target for the treatments of osteoporosis, psoriasis, cancer, and autoimmune diseases such as Crohn’s disease and sarcoidosis. The application of rational design and high throughput screening helped develop hit compounds into novel inhibitors for VDR-coregulator interactions. The techniques used included different biochemical and cell-based assays for nuclear receptors, multi-step and parallel synthesis, and analysis such as NMR and LCMS. Molecular modeling was used to identify new analogs based on docking as well as calculations of preclinical properties.

Part 2. Developed a universal kinase and GTPase Assay kit in collaboration with AviMed Pharmaceuticals LLC. This included the synthesis of assay components, development, miniaturization, and quality control.


  1. Teske, K. A.; Dash, R. C.; Morel, S. R.; Chau, L. Q.; Wechsler-Reya, R. J.; Hadden, M. K. Development of Posaconazole- Based Analogues as Hedgehog Signaling Pathway Inhibitors. Euro. J. Med. Chem. 2019, 163, 320-332.
  2. Teske, K. A.; Bogart, J. W.; Arnold, L. A.. Novel VDR antagonist based on the GW9742 scaffold. Biorg. Med. Chem. Lett., 2017, 28, 351-354.
  3. Teske, K. A.; Rai, G.; Nandhikonda, P.; Sidhu, Preetpal S. S.; Feleke, B.; Simeonov, A; Yasgar, A.; Jadjav, A.; Maloney, D.; Arnold, L. A., A Parallel Chemistry Approach to Identify Novel Nuclear Receptor Ligands Based on GW0742 Scaffold. ACS Combinatorial Science, 2017, 19, 646-656.
  4. Wang, Y.; Fan, H.; Balakrishnan, K.; Lin, Z.; Cao, S.; Chen, W.; Fan, Y.; Guthrie, Q.; Sun, H.; Teske, K. A.; Gandhi, V.; Arnold, L. A.; Peng, Peng, X., Hydrogen Peroxide Activated Quinone Methide Precursors with Enhanced DNA Cross-Linking Capability and Cytotoxicity Towards Cancer Cells. Euro. J. Med. Chem. 2017, 133, 197-207.
  5. Teske, K. A.; Hadden, M. K., Methyllysine Binding Domains: Structural Insight and Small Molecule Probe Development. Euro. J. Med. Chem. 2017, 136, 14-35.
  6. Michael M. Poe, Kashi R. Methuku, Guanguan Li, Ashwini Verma, Kelly A. Teske, Douglas C. Stafford, Leggy A. Arnold, Jeffrey W. Cramer, Timothy M. Jones, Rok Cerne, Michael J. Krambis, Jeffrey M. Witkin, Enrique Jambrina, Sabah Rehman, Margot Ernst, James M. Cook and Jeffrey M. Schkeryantz “Synthesis and characterization of a novel GABAA receptor ligand that combines outstanding metabolic stability, pharmacokinetics, and anxiolytic efficacy" Journal of Medicinal Chemistry 2016, 59, 10800-10806.
  7. Kelly A. Teske, Olivia B. Yu, and Leggy A. Arnold, “Inhibitors for the Vitamin D Receptor–Coregulator InteractionVitamin and Hormones 2016, 100, 45-82.
  8. Kelly A. Teske, Jonathon W. Bogart, Luis M. Sanchez, Olivia B. Yu, Joshua V. Preston, James M. Cook, Nicholas R. Silvaggi, Daniel D. Bikle, and Leggy A. Arnold, “Synthesis and Evaluation of Vitamin D Receptor-Mediated Activities of Cholesterol and Vitamin D Metabolites European Journal of Medicinal Chemistry 2016, 109, 238-246.
  9. Margaret L Guthrie, Preetpal S. Sidhu, Emily K. Hill, Timothy C. Horan, Premchendar Nandhikonda, Kelly A. Teske, Nina Y. Yuan, Marino Sidorko, Revathi Kodali, James M. Cook, Lanlan Han, Nicholas R. Silvaggi, Daniel D. Bikle, Richard G. Moore, Rakesh K. Singh, and Leggy A. Arnold “Antitumor activity of 3-Indolylmethanamines 31B and PS121912Anticancer Research 2015, 35(11), 6001-6007.
  10. Preetpal S. Sidhu, Kelly A. Teske, Belaynesh Feleke, Nina Y. Yuan, Margaret L. Guthrie, Grant B. Fernstrum, Nishita D. Vyas, Lanlan Han, Joshua Preston, Jonathan W. Bogart, Nicholas R. Silvaggi, James M. Cook, Rakesh K. Singh, Daniel D. Bikle, Leggy A. Arnold “Anticancer Activity of VDR-Coregulator Inhibitor PS121912Cancer Chemotherapy and Pharmacology 2014, 74(4), 787-798.
  11. Kelly A. Teske, Premchendar Nandhikonda, Jonathan W. Bogart, Belaynesh Feleke, Preetpal Sidhu, Nina Y. Yuan, Joshua Preston, Robin Goy, Rakesh K. Singh, Daniel D. Bikle, James M. Cook, Leggy A. Arnold “Identification of VDR antagonists among nuclear receptor ligands using virtual screeningNuclear Receptor Research 2014, 1, 1-8.
  12. Preetpal S. Sidhu, Nicholas Nassif, Megan M. McCallum, Kelly A. Teske, Belaynesh Feleke, Nina Y. Yuan, Premchendar Nandhikonda, James M. Cook, Rakesh K. Singh, Daniel D. Bikle, Leggy A. Arnold “Vitamin D Receptor-Coactivator Binding InhibitorsACS Medicinal Chemistry Letters 2014, 5(2), 199-204.
  13. Kelly A. Teske, Premchendar Nandhikonda, Jonathan W. Bogart, Belaynesh Feleke, Preetpal Sidhu, Nina Y. Yuan, Joshua Preston, Robin Goy, Leggy A. Arnold “Modulation of Transcription mediated by the Vitamin D Receptor and the Peroxisome Proliferator-Activated Receptor δ in the presence of GW0742 analogsJournal of Biomolecular Research and Therapeutics 2014, 3, e111.
  14. Premchendar Nandhikonda, Adam Yasgar, Athena M. Baranowski, Preetpal S. Sidhu, Megan M. McCallum, Alan J. Pawlak, Kelly A. Teske, Belaynesh Feleke, Nina Y. Yuan, Chinedum Kevin, Daniel D. Bikle, Steven D. Ayers, Paul Webb, Ganesha Rai, Anton Simeonov, Ajit Jadhav, David Maloney, Leggy A. Arnold “PPARδ agonist GW0742 interacts weakly with multiple nuclear receptors including the vitamin D receptorBiochemistry 2013, 52, 4193-4203.